Cargando…

Disease Burden Attributable to the First Wave of COVID-19 in China and the Effect of Timing on the Cost-Effectiveness of Movement Restriction Policies

OBJECTIVES: Movement restriction policies (MRPs) are effective in preventing/delaying COVID-19 transmission but are associated with high societal cost. This study aims to estimate the health burden of the first wave of COVID-19 in China and the cost-effectiveness of early versus late implementation...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jidi, Jin, Huajie, Li, Xun, Jia, Jianguo, Zhang, Chao, Zhao, Huijuan, Ma, Wuren, Wang, Zhuozhu, He, Yi, Lee, Jimmy, Zhang, Donglan, Yin, Bo, Zheng, Weiwei, Wang, Haiyin, Pennington, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897405/
https://www.ncbi.nlm.nih.gov/pubmed/33933229
http://dx.doi.org/10.1016/j.jval.2020.12.009
_version_ 1783653663197102080
author Zhao, Jidi
Jin, Huajie
Li, Xun
Jia, Jianguo
Zhang, Chao
Zhao, Huijuan
Ma, Wuren
Wang, Zhuozhu
He, Yi
Lee, Jimmy
Zhang, Donglan
Yin, Bo
Zheng, Weiwei
Wang, Haiyin
Pennington, Mark
author_facet Zhao, Jidi
Jin, Huajie
Li, Xun
Jia, Jianguo
Zhang, Chao
Zhao, Huijuan
Ma, Wuren
Wang, Zhuozhu
He, Yi
Lee, Jimmy
Zhang, Donglan
Yin, Bo
Zheng, Weiwei
Wang, Haiyin
Pennington, Mark
author_sort Zhao, Jidi
collection PubMed
description OBJECTIVES: Movement restriction policies (MRPs) are effective in preventing/delaying COVID-19 transmission but are associated with high societal cost. This study aims to estimate the health burden of the first wave of COVID-19 in China and the cost-effectiveness of early versus late implementation of MRPs to inform preparation for future waves. METHODS: The SEIR (susceptible, exposed, infectious, and recovered) modeling framework was adapted to simulate the health and cost outcomes of initiating MRPs at different times: rapid implementation (January 23, the real-world scenario), delayed by 1 week, delayed by 2 weeks, and delayed by 4 weeks. The end point was set as the day when newly confirmed cases reached zero. Two costing perspectives were adopted: healthcare and societal. Input data were obtained from official statistics and published literature. The primary outcomes were disability-adjusted life-years, cost, and net monetary benefit. Costs were reported in both Chinese renminbi (RMB) and US dollars (USD) at 2019 values. RESULTS: The first wave of COVID-19 in China resulted in 38 348 disability adjusted life-years lost (95% CI 19 417-64 130) and 2639 billion RMB losses (95% CI 1347-4688). The rapid implementation strategy dominated all other delayed strategies. This conclusion was robust to all scenarios tested. At a willingness-to-pay threshold of 70 892 RMB (the national annual GDP per capita) per disability-adjusted life-year saved, the probability for the rapid implementation to be the optimal strategy was 96%. CONCLUSIONS: Early implementation of MRPs in response to COVID-19 reduced both the health burden and societal cost and thus should be used for future waves of COVID-19.
format Online
Article
Text
id pubmed-7897405
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-78974052021-02-22 Disease Burden Attributable to the First Wave of COVID-19 in China and the Effect of Timing on the Cost-Effectiveness of Movement Restriction Policies Zhao, Jidi Jin, Huajie Li, Xun Jia, Jianguo Zhang, Chao Zhao, Huijuan Ma, Wuren Wang, Zhuozhu He, Yi Lee, Jimmy Zhang, Donglan Yin, Bo Zheng, Weiwei Wang, Haiyin Pennington, Mark Value Health Themed Section: COVID-19 OBJECTIVES: Movement restriction policies (MRPs) are effective in preventing/delaying COVID-19 transmission but are associated with high societal cost. This study aims to estimate the health burden of the first wave of COVID-19 in China and the cost-effectiveness of early versus late implementation of MRPs to inform preparation for future waves. METHODS: The SEIR (susceptible, exposed, infectious, and recovered) modeling framework was adapted to simulate the health and cost outcomes of initiating MRPs at different times: rapid implementation (January 23, the real-world scenario), delayed by 1 week, delayed by 2 weeks, and delayed by 4 weeks. The end point was set as the day when newly confirmed cases reached zero. Two costing perspectives were adopted: healthcare and societal. Input data were obtained from official statistics and published literature. The primary outcomes were disability-adjusted life-years, cost, and net monetary benefit. Costs were reported in both Chinese renminbi (RMB) and US dollars (USD) at 2019 values. RESULTS: The first wave of COVID-19 in China resulted in 38 348 disability adjusted life-years lost (95% CI 19 417-64 130) and 2639 billion RMB losses (95% CI 1347-4688). The rapid implementation strategy dominated all other delayed strategies. This conclusion was robust to all scenarios tested. At a willingness-to-pay threshold of 70 892 RMB (the national annual GDP per capita) per disability-adjusted life-year saved, the probability for the rapid implementation to be the optimal strategy was 96%. CONCLUSIONS: Early implementation of MRPs in response to COVID-19 reduced both the health burden and societal cost and thus should be used for future waves of COVID-19. ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. 2021-05 2021-02-21 /pmc/articles/PMC7897405/ /pubmed/33933229 http://dx.doi.org/10.1016/j.jval.2020.12.009 Text en © 2021 ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Themed Section: COVID-19
Zhao, Jidi
Jin, Huajie
Li, Xun
Jia, Jianguo
Zhang, Chao
Zhao, Huijuan
Ma, Wuren
Wang, Zhuozhu
He, Yi
Lee, Jimmy
Zhang, Donglan
Yin, Bo
Zheng, Weiwei
Wang, Haiyin
Pennington, Mark
Disease Burden Attributable to the First Wave of COVID-19 in China and the Effect of Timing on the Cost-Effectiveness of Movement Restriction Policies
title Disease Burden Attributable to the First Wave of COVID-19 in China and the Effect of Timing on the Cost-Effectiveness of Movement Restriction Policies
title_full Disease Burden Attributable to the First Wave of COVID-19 in China and the Effect of Timing on the Cost-Effectiveness of Movement Restriction Policies
title_fullStr Disease Burden Attributable to the First Wave of COVID-19 in China and the Effect of Timing on the Cost-Effectiveness of Movement Restriction Policies
title_full_unstemmed Disease Burden Attributable to the First Wave of COVID-19 in China and the Effect of Timing on the Cost-Effectiveness of Movement Restriction Policies
title_short Disease Burden Attributable to the First Wave of COVID-19 in China and the Effect of Timing on the Cost-Effectiveness of Movement Restriction Policies
title_sort disease burden attributable to the first wave of covid-19 in china and the effect of timing on the cost-effectiveness of movement restriction policies
topic Themed Section: COVID-19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897405/
https://www.ncbi.nlm.nih.gov/pubmed/33933229
http://dx.doi.org/10.1016/j.jval.2020.12.009
work_keys_str_mv AT zhaojidi diseaseburdenattributabletothefirstwaveofcovid19inchinaandtheeffectoftimingonthecosteffectivenessofmovementrestrictionpolicies
AT jinhuajie diseaseburdenattributabletothefirstwaveofcovid19inchinaandtheeffectoftimingonthecosteffectivenessofmovementrestrictionpolicies
AT lixun diseaseburdenattributabletothefirstwaveofcovid19inchinaandtheeffectoftimingonthecosteffectivenessofmovementrestrictionpolicies
AT jiajianguo diseaseburdenattributabletothefirstwaveofcovid19inchinaandtheeffectoftimingonthecosteffectivenessofmovementrestrictionpolicies
AT zhangchao diseaseburdenattributabletothefirstwaveofcovid19inchinaandtheeffectoftimingonthecosteffectivenessofmovementrestrictionpolicies
AT zhaohuijuan diseaseburdenattributabletothefirstwaveofcovid19inchinaandtheeffectoftimingonthecosteffectivenessofmovementrestrictionpolicies
AT mawuren diseaseburdenattributabletothefirstwaveofcovid19inchinaandtheeffectoftimingonthecosteffectivenessofmovementrestrictionpolicies
AT wangzhuozhu diseaseburdenattributabletothefirstwaveofcovid19inchinaandtheeffectoftimingonthecosteffectivenessofmovementrestrictionpolicies
AT heyi diseaseburdenattributabletothefirstwaveofcovid19inchinaandtheeffectoftimingonthecosteffectivenessofmovementrestrictionpolicies
AT leejimmy diseaseburdenattributabletothefirstwaveofcovid19inchinaandtheeffectoftimingonthecosteffectivenessofmovementrestrictionpolicies
AT zhangdonglan diseaseburdenattributabletothefirstwaveofcovid19inchinaandtheeffectoftimingonthecosteffectivenessofmovementrestrictionpolicies
AT yinbo diseaseburdenattributabletothefirstwaveofcovid19inchinaandtheeffectoftimingonthecosteffectivenessofmovementrestrictionpolicies
AT zhengweiwei diseaseburdenattributabletothefirstwaveofcovid19inchinaandtheeffectoftimingonthecosteffectivenessofmovementrestrictionpolicies
AT wanghaiyin diseaseburdenattributabletothefirstwaveofcovid19inchinaandtheeffectoftimingonthecosteffectivenessofmovementrestrictionpolicies
AT penningtonmark diseaseburdenattributabletothefirstwaveofcovid19inchinaandtheeffectoftimingonthecosteffectivenessofmovementrestrictionpolicies